This site is intended for healthcare professionals only
LoginRegister
ZydusZydus Lifesciences Gets CDSCO Panel Nod to Market Semaglutide Injection for Type 2 Diabetes
Aurobindo Arm CuraTeQ Gets Health Canada NOC for Pegfilgrastim Biosimilar DyrupeAurobindo Arm CuraTeQ Gets Health Canada NOC for Pegfilgrastim Biosimilar Dyrupe
Online Platform Offers India-Sourced Ozempic to US Consumers at Steep DiscountsOnline Platform Offers India-Sourced Ozempic to US Consumers at Steep Discounts
Amid Debt Pressure, Sun Pharmas Research Arm SPARC Plans 40% Workforce ReductionAmid Debt Pressure, Sun Pharma's Research Arm SPARC Plans 40% Workforce Reduction
Merck in Talks to Acquire Revolution Medicines in USD 28-32 Billion Oncology DealMerck in Talks to Acquire Revolution Medicines in USD 28-32 Billion Oncology Deal
Eli Lilly Expands Immunology Pipeline with USD 1.2 Billion Ventyx BuyoutEli Lilly Expands Immunology Pipeline with USD 1.2 Billion Ventyx Buyout
Pharma Firm Slapped Rs 15 Lakh for Infringing IPCAs ZERODOL TrademarkPharma Firm Slapped Rs 15 Lakh for Infringing IPCA's ZERODOL Trademark
Gland Pharma Gets USFDA Approval for Olopatadine Ophthalmic SolutionGland Pharma Gets USFDA Approval for Olopatadine Ophthalmic Solution
Torrent Pharma to Raise Up to Rs 12,500 Cr via Bonds for JB Chemicals DealTorrent Pharma to Raise Up to Rs 12,500 Cr via Bonds for JB Chemicals Deal
DCA Raids Illegal Clinic in Telangana, Seizes Antibiotics, SteroidsDCA Raids Illegal Clinic in Telangana, Seizes Antibiotics, Steroids
CCTV Mandate at Pharmacies for Schedule Drugs in Delhi Draws Objections from RDCACCTV Mandate at Pharmacies for Schedule Drugs in Delhi Draws Objections from RDCA
USFDA Grants Tentative Approval, 180-Day Exclusivity to Granules Generic Amphetamine XRUSFDA Grants Tentative Approval, 180-Day Exclusivity to Granules' Generic Amphetamine XR
X